| Literature DB >> 29747006 |
Pedro Lavrador1, Vitor M Gaspar2, João F Mano3.
Abstract
The use of natural compounds for treating chronic bone diseases holds remarkable potential. Among these therapeutics, naringin, a flavanone glycoside, represents one of the most promising candidates owing to its multifaceted effect on bone tissues. This review provides an up-to-date overview on naringin applications in the treatment of bone disorders, such as osteoporosis and osteoarthritis, and further highlights its potential for stem cell pro-osteogenic differentiation therapies. A critical perspective on naringin clinical translation is also provided. The topic is discussed in light of recently developed biomaterial-based approaches that potentiate its bioavailability and bioactivity. Overall, the reported pro-osteogenic, antiresorptive and antiadipogenic properties establish this flavanone as an exciting candidate for application in bone tissue engineering and regenerative medicine.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29747006 DOI: 10.1016/j.drudis.2018.05.012
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851